Skip to main content
SpringerLink
Log in

The human protein atlas

  • Review Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Clamp M, Fry B, Kamal M, et al. Distinguishing protein-coding and noncoding genes in the humangenome. Proc Natl Acad Sci USA 2007;104:19428–19433.

    Article  PubMed  CAS  Google Scholar 

  2. Uhlen M. Mapping the human proteome using antibodies. Mol Cell Proteom 2007;6:1455–1456.

    CAS  Google Scholar 

  3. Berglund L, Björling E, Oksvold P, et al. A genecentric human protein atlas for expression profiles based on antibodies. Mol Cell Proteomics 2008;10:2019–2027.

    Google Scholar 

  4. Rimm DL, Camp RL, Charette LA, et al Tissue microarray: a new technology for amplification of tissue resources. Cancer J 2001;7:24–31.

    PubMed  CAS  Google Scholar 

  5. Kallioniemi OP, Wagner U, Kononen J, et al Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001;10:657–662.

    Article  PubMed  CAS  Google Scholar 

  6. Brennan DJ, Kelly C, Rexhepaj E, et al. Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer. Cancer Genom Proteom 2007;4:121–134.

    CAS  Google Scholar 

  7. Nandkumar A, editor. Biennial Report (1990–96) of National Cancer Registry Programme, Indian Council of Medical Research: New Delhi. Publ National Printing Press: Bangalore; 2001: 62–63.

    Google Scholar 

  8. Jemal A, Siegel R, Ward E, et al Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–249.

    Article  PubMed  Google Scholar 

  9. Ehlén A, Brennan DJ, Nodin B, et al. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. Journal of Translational Medicine 2010;8:78.

    Article  PubMed  Google Scholar 

  10. Han ES, Lin P, Wakabayashi M. Current status on biologic therapies in the treatment of epithelial ovarian cancer. Curr Treat Options Oncol 2009;10:54–66.

    Article  PubMed  Google Scholar 

  11. Tummala MK, McGuire WP. Recurrent ovarian cancer. Clin Adv Hematol Oncol 2005;3:723–736.

    PubMed  Google Scholar 

  12. Jogi A, Brennan DJ, Ryden L, et al: Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer. Mod Pathol 2009;22:1564–1574.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School, Boston, USA

    Sanjay Navani

  2. Lab Surgpath, 204 Bombay Market 731/1 Tardeo Main Road, Mumbai, 400 034, India

    Sanjay Navani

Authors
  1. Sanjay Navani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjay Navani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Navani, S. The human protein atlas. J Obstet Gynecol India 61, 27–31 (2011). https://doi.org/10.1007/s13224-011-0013-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-011-0013-z

Keywords

Search

Navigation